Cholera Vaccine Market

The global cholera vaccines market size reached US$ 4.9 Million in 2022. By 2028, it will reach a value of US$ 9.2 Million, CAGR of 11.1% during (2023-2028).

SHERIDAN, WYOMING, USA, April 10, 2023 /EINPresswire.com/ -- Cholera vaccines are biological preparations that assist in strengthening the immune system and provide immunity against cholera. It also helps in minimizing the risk of bacterial infections that may spread through contaminated food and water and leads to abdominal pain, fever, rapid heart rate, loss of skin elasticity, low blood pressure, muscle cramps, and dry mucous membranes. At present, it includes the oral cholera vaccine (OCV) that protects against cholera for up to two years, and the injectable cholera vaccine (ICV), which facilitates prevention for six months.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/cholera-vaccines-market/requestsample

Cholera Vaccines Market Trends and Drivers:

The growing global population and increasing focus on prevention and control of cholera in areas with poor sanitation and hygiene currently represent one of the key factors positively influencing the market across the globe.

In addition, governments and private organizations are introducing favorable health initiatives for the prevention and control of infectious diseases like cholera. This, along with the growing awareness about the importance and effectiveness of cholera vaccines among the people, is creating a favorable market outlook.

Apart from this, increasing investments in research and development (R&D) activities for developing new vaccine formulations for cholera, including single-dose vaccines and heat-stable vaccines that do not require refrigeration, are stimulating the growth of the market around the world.

Global Cholera Vaccines Market 2023-2028 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Astellas Pharma Inc., Celldex Therapeutics Inc. (Avant Immunotherapeutics Inc.), Emergent BioSolutions Inc., Eubiologics Co. Ltd., Johnson & Johnson, Merck & Co. Inc, Pfizer Inc., PharmaChoice Canada Inc, Sanofi S.A., Takeda Pharmaceutical Company Limited and Valneva SE.

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/cholera-vaccines-market

The report has segmented the market on the basis of region, vaccine type, product and end user.

Breakup by Vaccine Type:
• Whole Cell V. Cholerae O1 with Recombinant B-Subunit
• Killed Oral O1 and O139

Breakup by Product:
• Dukoral
• Shanchol
• Vaxchora
• Euvichol and Euvichol-Plus
• Others

Breakup by End User:
• Hospitals and Clinics
• Research and Academic Laboratories
• Others

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:
• Market Performance (2017-2022)
• Market Outlook (2023- 2028)
• Porter’s Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse Other Reports:

India Used Cooking Oil Market Size 2023 | Latest Trends, Key Players, Revenue, Risks Factors Analysis by 2028

Osseointegration Implants Market Size to Reach US$ 8,747.7 Million by Forecast 2027

Over The Counter (OTC) Drugs Market Size Expected to Cross US$ 212.6 Billion by 2027 | CAGR 6.44%

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Services Private Limited.
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Anand Ranjan
IMARC Services Private Limited
+1 6317911145
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.